CVRX Insider Trading

Insider Ownership Percentage: 18.90%
Insider Buying (Last 12 Months): $322,545.00
Insider Selling (Last 12 Months): $19,419.40

CVRx Insider Trading History Chart

This chart shows the insider buying and selling history at CVRx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$400k-$200k$0$200k$400kTotal Insider BuyingTotal Insider Selling

CVRx Share Price & Price History

Current Price: $11.75
Price Change: Price Increase of +0.31 (2.71%)
As of 03/17/2025 05:00 PM ET

This chart shows the closing price history over time for CVRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
AprMayJunJulAugSepOctNovDecJanFebMar$11.75Closing price on 03/17/25:

SEC Filings (Institutional Ownership Changes) for CVRx (NASDAQ:CVRX)

75.27% of CVRx stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CVRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$24Mbought$13MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$20M-$10M$0$10M$20MTotal InflowsTotal Outflows
CVRx logo
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Read More on CVRx

Today's Range

Now: $11.75
Low: $11.20
High: $11.82

50 Day Range

MA: $14.59
Low: $11.05
High: $18.40

52 Week Range

Now: $11.75
Low: $6.40
High: $21.67

Volume

91,729 shs

Average Volume

283,330 shs

Market Capitalization

$305.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Who are the company insiders with the largest holdings of CVRx?

CVRx's top insider shareholders include:
  1. & Johnson Johnson (Major Shareholder)
  2. Joseph P Slattery (Director)
  3. Kevin Hykes (CEO)
  4. Paul Verrastro (Insider)
Learn More about top insider investors at CVRx.

Who are the major institutional investors of CVRx?

CVRx's top institutional shareholders include:
  1. NEA Management Company LLC — 8.35%
  2. Parkman Healthcare Partners LLC — 3.80%
  3. JPMorgan Chase & Co. — 2.59%
  4. Emerald Advisers LLC — 2.45%
  5. Millennium Management LLC — 1.67%
  6. Silvercrest Asset Management Group LLC — 1.53%
Learn More about top institutional investors of CVRx stock.

Which institutional investors are selling CVRx stock?

Within the last quarter, CVRX stock was sold by these institutional investors:
  1. NEA Management Company LLC
  2. Schonfeld Strategic Advisors LLC
  3. Balyasny Asset Management L.P.
  4. Marshall Wace LLP
  5. Cubist Systematic Strategies LLC
  6. Nuveen Asset Management LLC
  7. Archon Capital Management LLC
  8. Millennium Management LLC

Which institutional investors are buying CVRx stock?

Within the previous quarter, CVRX stock was purchased by institutional investors including:
  1. JPMorgan Chase & Co.
  2. Silvercrest Asset Management Group LLC
  3. Parkman Healthcare Partners LLC
  4. Emerald Advisers LLC
  5. Norges Bank
  6. Emerald Mutual Fund Advisers Trust
  7. Trexquant Investment LP
  8. Tradewinds LLC.
In the last year, these company insiders have bought CVRx stock:
  1. & Johnson Johnson (Major Shareholder)
  2. Joseph P Slattery (Director)
Learn More investors buying CVRx stock.